glp 1 pancreatic cancer GLP-1s appear to cut risk. Researchers are asking why and how : NPR Glucagon-like peptide-1 receptor agonists and
Description
This is particularly relevant for patients who have not achieved adequate lipid control with statins alone
That's a clinically meaningful result - it's larger than what any prior obesity pharmacotherapy had achieved at scale
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Since the growth of using semaglutide for weight loss started in the early 2020s, the USDA has noted falling deliveries of sugar for human consumption since GLP-1 drugs became mainstream
You might feel sluggish, cold, or see the scale tick up despite a solid diet
